Various Application of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective

INTRODUCTION: Janus kinase inhibitors (JAKi) are anti-inflammatory medications suppressing Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway by inhibiting various cytokines receptors on the membrane of cells. Mutations and polymorphisms on JAK and STAT proteins can cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Sara, Goodarzi, Azadeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681403/
https://www.ncbi.nlm.nih.gov/pubmed/36534552
http://dx.doi.org/10.5826/dpc.1204a178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681403/
https://www.ncbi.nlm.nih.gov/pubmed/36534552
http://dx.doi.org/10.5826/dpc.1204a178

Ejemplares similares